IL22 is essential for repairing lung tissue and maintaining epithelial cell homeostasis after an influenza virus infection, suggesting its promising role as an immunotherapy agent for interstitial lung disease [16,17]. This evidence concerns the gene IL22 and interstitial lung disease.